available edge detection routines Search Results


90
Medical Imaging Applications LLC edge-detection wall-tracking software
Edge Detection Wall Tracking Software, supplied by Medical Imaging Applications LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/edge-detection wall-tracking software/product/Medical Imaging Applications LLC
Average 90 stars, based on 1 article reviews
edge-detection wall-tracking software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Cognex Inc pattern recognition software
Pattern Recognition Software, supplied by Cognex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pattern recognition software/product/Cognex Inc
Average 90 stars, based on 1 article reviews
pattern recognition software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Medical Imaging Applications LLC edge detection software
Edge Detection Software, supplied by Medical Imaging Applications LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/edge detection software/product/Medical Imaging Applications LLC
Average 90 stars, based on 1 article reviews
edge detection software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Medis edge-detection algorithm cms
Edge Detection Algorithm Cms, supplied by Medis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/edge-detection algorithm cms/product/Medis
Average 90 stars, based on 1 article reviews
edge-detection algorithm cms - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Medis edge detection software qcacms version 5.2
Edge Detection Software Qcacms Version 5.2, supplied by Medis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/edge detection software qcacms version 5.2/product/Medis
Average 90 stars, based on 1 article reviews
edge detection software qcacms version 5.2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

96
MathWorks Inc available edge detection routines
Figure 3. Left) Actual image of a pendant drop; Right) Binary image resulting from <t>edge</t> <t>detection</t> (color figure <t>available</t> online).
Available Edge Detection Routines, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/available edge detection routines/product/MathWorks Inc
Average 96 stars, based on 1 article reviews
available edge detection routines - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
Biomol GmbH fatty alcohol phosphate (fap-12)
Figure 3. Left) Actual image of a pendant drop; Right) Binary image resulting from <t>edge</t> <t>detection</t> (color figure <t>available</t> online).
Fatty Alcohol Phosphate (Fap 12), supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fatty alcohol phosphate (fap-12)/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
fatty alcohol phosphate (fap-12) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Neuropharm Ltd lysophosphatidic acid receptors (lpars)
Figure 3. Left) Actual image of a pendant drop; Right) Binary image resulting from <t>edge</t> <t>detection</t> (color figure <t>available</t> online).
Lysophosphatidic Acid Receptors (Lpars), supplied by Neuropharm Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lysophosphatidic acid receptors (lpars)/product/Neuropharm Ltd
Average 90 stars, based on 1 article reviews
lysophosphatidic acid receptors (lpars) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Kitayama Labes Co Ltd lysophosphatidic acid receptor-2
Figure 3. Left) Actual image of a pendant drop; Right) Binary image resulting from <t>edge</t> <t>detection</t> (color figure <t>available</t> online).
Lysophosphatidic Acid Receptor 2, supplied by Kitayama Labes Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lysophosphatidic acid receptor-2/product/Kitayama Labes Co Ltd
Average 90 stars, based on 1 article reviews
lysophosphatidic acid receptor-2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
ApexBio lpa 1 receptor antagonist am095
Inhibition of LPA 1 mitigates disease severity in EAN. a Active EAN was induced in Lewis rats, which were treated with the LPA 1 receptor antagonist <t>AM095</t> once daily after developing first clinical symptoms at 10 dpi. While there was no significant impact of AM095 around the peak of disease, disease severity was significantly ameliorated over the course of the remission phase. A significant difference was observed from 20 dpi until the end of the experiment at 28 dpi. Each dot indicates mean clinical scores ± s.e.m. b Cumulative clinical scores of individual animals obtained from day 0 to the end of the experiment at 28 dpi. Animals were pooled from three independent experiments. N = 21 (Vehicle)/23 (AM095). c Representative images of semi-thin toluidine blue-stained sections of sciatic nerves at 28 dpi. d Axon diameter histogram indicates a significant increase in the number of large-caliber (≥ 8 µm) myelinated axons following AM095 treatment ( N = 4). e G-ratios were plotted against axon diameters; overlapping results indicate comparability of both treatment groups with regard to axon diameter distributions and myelination. f In accordance with this finding, the assessment of g-ratios (the numerical ratio between axonal and myelinated fiber diameter) does not indicate any differences with regard to myelin thickness ( N = 4). Data represent mean ± s.e.m. P ≤ 0.05*. Scale bar indicates 50 µm
Lpa 1 Receptor Antagonist Am095, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lpa 1 receptor antagonist am095/product/ApexBio
Average 90 stars, based on 1 article reviews
lpa 1 receptor antagonist am095 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Albaugh LLC lysophosphatidic acid receptor 1
Inhibition of LPA 1 mitigates disease severity in EAN. a Active EAN was induced in Lewis rats, which were treated with the LPA 1 receptor antagonist <t>AM095</t> once daily after developing first clinical symptoms at 10 dpi. While there was no significant impact of AM095 around the peak of disease, disease severity was significantly ameliorated over the course of the remission phase. A significant difference was observed from 20 dpi until the end of the experiment at 28 dpi. Each dot indicates mean clinical scores ± s.e.m. b Cumulative clinical scores of individual animals obtained from day 0 to the end of the experiment at 28 dpi. Animals were pooled from three independent experiments. N = 21 (Vehicle)/23 (AM095). c Representative images of semi-thin toluidine blue-stained sections of sciatic nerves at 28 dpi. d Axon diameter histogram indicates a significant increase in the number of large-caliber (≥ 8 µm) myelinated axons following AM095 treatment ( N = 4). e G-ratios were plotted against axon diameters; overlapping results indicate comparability of both treatment groups with regard to axon diameter distributions and myelination. f In accordance with this finding, the assessment of g-ratios (the numerical ratio between axonal and myelinated fiber diameter) does not indicate any differences with regard to myelin thickness ( N = 4). Data represent mean ± s.e.m. P ≤ 0.05*. Scale bar indicates 50 µm
Lysophosphatidic Acid Receptor 1, supplied by Albaugh LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lysophosphatidic acid receptor 1/product/Albaugh LLC
Average 90 stars, based on 1 article reviews
lysophosphatidic acid receptor 1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Blackwell Verlag lpa receptors
Inhibition of LPA 1 mitigates disease severity in EAN. a Active EAN was induced in Lewis rats, which were treated with the LPA 1 receptor antagonist <t>AM095</t> once daily after developing first clinical symptoms at 10 dpi. While there was no significant impact of AM095 around the peak of disease, disease severity was significantly ameliorated over the course of the remission phase. A significant difference was observed from 20 dpi until the end of the experiment at 28 dpi. Each dot indicates mean clinical scores ± s.e.m. b Cumulative clinical scores of individual animals obtained from day 0 to the end of the experiment at 28 dpi. Animals were pooled from three independent experiments. N = 21 (Vehicle)/23 (AM095). c Representative images of semi-thin toluidine blue-stained sections of sciatic nerves at 28 dpi. d Axon diameter histogram indicates a significant increase in the number of large-caliber (≥ 8 µm) myelinated axons following AM095 treatment ( N = 4). e G-ratios were plotted against axon diameters; overlapping results indicate comparability of both treatment groups with regard to axon diameter distributions and myelination. f In accordance with this finding, the assessment of g-ratios (the numerical ratio between axonal and myelinated fiber diameter) does not indicate any differences with regard to myelin thickness ( N = 4). Data represent mean ± s.e.m. P ≤ 0.05*. Scale bar indicates 50 µm
Lpa Receptors, supplied by Blackwell Verlag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lpa receptors/product/Blackwell Verlag
Average 90 stars, based on 1 article reviews
lpa receptors - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Figure 3. Left) Actual image of a pendant drop; Right) Binary image resulting from edge detection (color figure available online).

Journal: International Journal of Optomechatronics

Article Title: Measurement of Surface Interfacial Tension as a Function of Temperature Using Pendant Drop Images

doi: 10.1080/15599612.2011.633206

Figure Lengend Snippet: Figure 3. Left) Actual image of a pendant drop; Right) Binary image resulting from edge detection (color figure available online).

Article Snippet: This could be achieved using available edge detection routines (for example, MATLAB’s image processing toolbox, Photoshop, etc.).

Techniques:

Inhibition of LPA 1 mitigates disease severity in EAN. a Active EAN was induced in Lewis rats, which were treated with the LPA 1 receptor antagonist AM095 once daily after developing first clinical symptoms at 10 dpi. While there was no significant impact of AM095 around the peak of disease, disease severity was significantly ameliorated over the course of the remission phase. A significant difference was observed from 20 dpi until the end of the experiment at 28 dpi. Each dot indicates mean clinical scores ± s.e.m. b Cumulative clinical scores of individual animals obtained from day 0 to the end of the experiment at 28 dpi. Animals were pooled from three independent experiments. N = 21 (Vehicle)/23 (AM095). c Representative images of semi-thin toluidine blue-stained sections of sciatic nerves at 28 dpi. d Axon diameter histogram indicates a significant increase in the number of large-caliber (≥ 8 µm) myelinated axons following AM095 treatment ( N = 4). e G-ratios were plotted against axon diameters; overlapping results indicate comparability of both treatment groups with regard to axon diameter distributions and myelination. f In accordance with this finding, the assessment of g-ratios (the numerical ratio between axonal and myelinated fiber diameter) does not indicate any differences with regard to myelin thickness ( N = 4). Data represent mean ± s.e.m. P ≤ 0.05*. Scale bar indicates 50 µm

Journal: Journal of Neuroinflammation

Article Title: LPA 1 signaling drives Schwann cell dedifferentiation in experimental autoimmune neuritis

doi: 10.1186/s12974-021-02350-5

Figure Lengend Snippet: Inhibition of LPA 1 mitigates disease severity in EAN. a Active EAN was induced in Lewis rats, which were treated with the LPA 1 receptor antagonist AM095 once daily after developing first clinical symptoms at 10 dpi. While there was no significant impact of AM095 around the peak of disease, disease severity was significantly ameliorated over the course of the remission phase. A significant difference was observed from 20 dpi until the end of the experiment at 28 dpi. Each dot indicates mean clinical scores ± s.e.m. b Cumulative clinical scores of individual animals obtained from day 0 to the end of the experiment at 28 dpi. Animals were pooled from three independent experiments. N = 21 (Vehicle)/23 (AM095). c Representative images of semi-thin toluidine blue-stained sections of sciatic nerves at 28 dpi. d Axon diameter histogram indicates a significant increase in the number of large-caliber (≥ 8 µm) myelinated axons following AM095 treatment ( N = 4). e G-ratios were plotted against axon diameters; overlapping results indicate comparability of both treatment groups with regard to axon diameter distributions and myelination. f In accordance with this finding, the assessment of g-ratios (the numerical ratio between axonal and myelinated fiber diameter) does not indicate any differences with regard to myelin thickness ( N = 4). Data represent mean ± s.e.m. P ≤ 0.05*. Scale bar indicates 50 µm

Article Snippet: The LPA 1 receptor antagonist AM095 [ ] was obtained from ApexBio (Houston, TX, USA) and dissolved in phosphate buffered saline (PBS) containing 0.5% methylcellulose (Sigma-Aldrich).

Techniques: Inhibition, Staining

Minor impact of AM095 treatment on immune cell infiltration. Immune cell infiltration was assessed by counting the number of CD3 + (T-lymphocytes) and CD11b/c + (myeloid cells) on sciatic nerve sections in randomly selected fields. a Representative images of immune cell infiltration at peak of disease at 14 dpi, and early remission phase at 21 dpi. b + c No significant difference was observed in the number of infiltrating CD3+ cells between peak of disease and remission phase ( N = 9/8/4/4 from left to right). d + e While there was no significant reduction in CD3 + cells at 14 dpi, we recognized a slight decrease in myeloid cells under AM095 at 21 dpi ( N = 5/5/5/6 from left to right)). Cell counts were normalized to area. Data represent mean ± s.e.m. P ≤ 0.05*. Scale bars indicate 50 µm

Journal: Journal of Neuroinflammation

Article Title: LPA 1 signaling drives Schwann cell dedifferentiation in experimental autoimmune neuritis

doi: 10.1186/s12974-021-02350-5

Figure Lengend Snippet: Minor impact of AM095 treatment on immune cell infiltration. Immune cell infiltration was assessed by counting the number of CD3 + (T-lymphocytes) and CD11b/c + (myeloid cells) on sciatic nerve sections in randomly selected fields. a Representative images of immune cell infiltration at peak of disease at 14 dpi, and early remission phase at 21 dpi. b + c No significant difference was observed in the number of infiltrating CD3+ cells between peak of disease and remission phase ( N = 9/8/4/4 from left to right). d + e While there was no significant reduction in CD3 + cells at 14 dpi, we recognized a slight decrease in myeloid cells under AM095 at 21 dpi ( N = 5/5/5/6 from left to right)). Cell counts were normalized to area. Data represent mean ± s.e.m. P ≤ 0.05*. Scale bars indicate 50 µm

Article Snippet: The LPA 1 receptor antagonist AM095 [ ] was obtained from ApexBio (Houston, TX, USA) and dissolved in phosphate buffered saline (PBS) containing 0.5% methylcellulose (Sigma-Aldrich).

Techniques:

Hemogram profiles indicate no impact of AM095 a circulating leukocytes. At 21 dpi, hemogram profiles were generated from blood samples taken by cardiac puncture immediately after animals were sacrificed. No differences were detected in basic parameters including a erythrocytes, hemoglobin (HGB), hematocrit (HCT) and b platelets. c The total number of circulating leukocytes was unaffected by treatment with AM095. d Coherently, no significant differences were observed for subpopulations including lymphocytes, neutrophils, monocytes, eosinophils and basophils. Data represent mean ± s.e.m. N = 7 for each column

Journal: Journal of Neuroinflammation

Article Title: LPA 1 signaling drives Schwann cell dedifferentiation in experimental autoimmune neuritis

doi: 10.1186/s12974-021-02350-5

Figure Lengend Snippet: Hemogram profiles indicate no impact of AM095 a circulating leukocytes. At 21 dpi, hemogram profiles were generated from blood samples taken by cardiac puncture immediately after animals were sacrificed. No differences were detected in basic parameters including a erythrocytes, hemoglobin (HGB), hematocrit (HCT) and b platelets. c The total number of circulating leukocytes was unaffected by treatment with AM095. d Coherently, no significant differences were observed for subpopulations including lymphocytes, neutrophils, monocytes, eosinophils and basophils. Data represent mean ± s.e.m. N = 7 for each column

Article Snippet: The LPA 1 receptor antagonist AM095 [ ] was obtained from ApexBio (Houston, TX, USA) and dissolved in phosphate buffered saline (PBS) containing 0.5% methylcellulose (Sigma-Aldrich).

Techniques: Generated

AM095 treatment decreases the number of dedifferentiating Schwann cells. Schwann cell dedifferentiation was investigated via immunohistochemistry by counting the number Sox2-positive cells in randomly selected fields on sciatic nerve sections. a + b A significant reduction of Sox2-positive cells with AM095 was observed at 21 dpi ( N = 5/5). c + d This effect was even more pronounced at 28 dpi ( N = 8/8). e + f In accordance with this finding, the number of differentiated Sox10-positive cells was significantly increased under treatment with AM095 at 28 dpi ( N = 8/8). The number of Sox2/10-positive cells was related to the total number of cells stained with DAPI and normalized to vehicle-treated controls. Data represent normalized mean ± s.e.m. P ≤ 0.05*, P ≤ 0.01**. Scale bars indicate 50 µm

Journal: Journal of Neuroinflammation

Article Title: LPA 1 signaling drives Schwann cell dedifferentiation in experimental autoimmune neuritis

doi: 10.1186/s12974-021-02350-5

Figure Lengend Snippet: AM095 treatment decreases the number of dedifferentiating Schwann cells. Schwann cell dedifferentiation was investigated via immunohistochemistry by counting the number Sox2-positive cells in randomly selected fields on sciatic nerve sections. a + b A significant reduction of Sox2-positive cells with AM095 was observed at 21 dpi ( N = 5/5). c + d This effect was even more pronounced at 28 dpi ( N = 8/8). e + f In accordance with this finding, the number of differentiated Sox10-positive cells was significantly increased under treatment with AM095 at 28 dpi ( N = 8/8). The number of Sox2/10-positive cells was related to the total number of cells stained with DAPI and normalized to vehicle-treated controls. Data represent normalized mean ± s.e.m. P ≤ 0.05*, P ≤ 0.01**. Scale bars indicate 50 µm

Article Snippet: The LPA 1 receptor antagonist AM095 [ ] was obtained from ApexBio (Houston, TX, USA) and dissolved in phosphate buffered saline (PBS) containing 0.5% methylcellulose (Sigma-Aldrich).

Techniques: Immunohistochemistry, Staining